Cross-Sectional Survey on the Use of Tobacco Products in the General Population and in Users of IQOS in Germany (2018-2020)
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Tobacco Use
- Sponsor
- Philip Morris Products S.A.
- Enrollment
- 6284
- Locations
- 1
- Primary Endpoint
- Self-reported health status
- Status
- Terminated
- Last Updated
- 2 years ago
Overview
Brief Summary
The main purpose of the research study is to estimate the prevalence of tobacco product use and describe the tobacco use patterns in adults in Germany.
Detailed Description
The aim of the survey is to describe the current and past patterns of use of tobacco products in the general adult population of Germany and in adult IQOS users registered in the IQOS user database of Philip Morris GmbH (Germany IQOS User Database), and explore their association with key independent variables. More specifically, the objectives are: 1. Estimate the prevalence of current tobacco use status in the study population. 2. Describe the past tobacco use status (cigarette, IQOS and other innovative products, including e-cigarettes) in the study population (i.e. never-use, initiation, product use transition, cessation, re-initiation, and relapse). 3. Explore the association between self-reported health status and use of tobacco products in the study population. 4. Explore the association between patterns of use (including misuse) with motivation to use, perceived quality attributes of IQOS (e.g. risk and self-reported changes since switching to the product, in a number of relevant domains where IQOS may have potential benefits), and consumer's satisfaction in the population of IQOS users in Germany registered in the Germany IQOS User Database.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Not meeting the inclusion criteria
Outcomes
Primary Outcomes
Self-reported health status
Time Frame: Study duration (3 years).
Association between self-reported health status and use of tobacco products in the study population.
IQOS use experience
Time Frame: Study duration (3 years).
Describe the IQOS user experience, including motivation to use, mis-use, satisfaction, and self-reported changes since switching to the product (in a number of domains where IQOS may have potential benefits).
Perceived risk
Time Frame: Study duration (3 years).
Association between patterns of use with perceived risk.
Prevalence of current tobacco use
Time Frame: Study duration (3 years).
Prevalence of current tobacco use status in the study population.
Past tobacco use status
Time Frame: Study duration (3 years).
Past tobacco use status (cigarette, IQOS and other innovative products) in the study population.